Directory
>
Kevin Capps
Kevin Capps
Executive Director, Head of Intellectual Property | Crinetics Pharmaceuticals
Henderson, Nevada, United States
Kevin Capps
Summary
Kevin Capps is a seasoned Pharmaceutical Patent Attorney with extensive experience in intellectual property law, particularly within the pharmaceutical and biotech sectors. He currently serves as the Executive Director and Head of Intellectual Property at Crinetics Pharmaceuticals, where he leverages his legal expertise to navigate complex patent landscapes. Kevin's career spans over 15 years, during which he has held significant roles at prominent companies such as Neurocrine Biosciences and AstraZeneca. He holds a PhD in Chemistry and a JD from the University of San Diego School of Law, showcasing a strong academic foundation that complements his legal practice. His work has not only contributed to patent strategy but also to advancing drug development processes. Kevin's interests lie in the intersection of law and science, focusing on how legal frameworks can support innovation in healthcare. He is known for his analytical skills and ability to communicate complex legal concepts to diverse audiences.
Kevin Capps
Work Experience
Executive Director, Head of Intellectual Property at
Crinetics Pharmaceuticals
January 2021 - Present
Senior Patent Counsel at
Neurocrine Biosciences
January 2020 - January 2021
Senior Patent Attorney at
AstraZeneca
January 2018 - January 2020
Senior Patent Counsel at
Gilead Sciences
January 2015 - January 2018
Associate at
Wilson Sonsini Goodrich & Rosati
January 2013 - January 2015
Associate at
Sheppard Mullin Richter & Hampton LLP
January 2011 - January 2013
Associate at
Knobbe Martens
January 2010 - January 2011
Patent Examiner at
Us Patent And Trademark Office
January 2005 - January 2007
Kevin Capps
Education
University of San Diego School of Law, Jd
January 2007 - January 2010
Scripps Research, Phd
January 2000 - January 2005
University of Maryland, Bs
January 1997 - January 2000
Frequently Asked Questions about Kevin Capps
What is Kevin Capps email address?
Kevin Capps's primary email address is ******@crinetics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kevin Capps work for?
Kevin Capps is a Executive Director, Head of Intellectual Property at Crinetics Pharmaceuticals, a company specializing in Commercial physical research.
Where Kevin Capps graduated from?
Kevin Capps holds a degree in from University of San Diego School of Law.
How can I directly contact Kevin Capps?
To contact Kevin Capps directly, you can use the email address ******@crinetics.com. Complete contact information is available upon registration with Muraena.
Who is Kevin Capps?
Kevin Capps is a seasoned Pharmaceutical Patent Attorney with extensive experience in intellectual property law, particularly within the pharmaceutical and biotech sectors. He currently serves as the Executive Director and Head of Intellectual Property at Crinetics Pharmaceuticals, where he leverages his legal expertise to navigate complex patent landscapes. Kevin's career spans over 15 years, during which he has held significant roles at prominent companies such as Neurocrine Biosciences and AstraZeneca. He holds a PhD in Chemistry and a JD from the University of San Diego School of Law, showcasing a strong academic foundation that complements his legal practice. His work has not only contributed to patent strategy but also to advancing drug development processes. Kevin's interests lie in the intersection of law and science, focusing on how legal frameworks can support innovation in healthcare. He is known for his analytical skills and ability to communicate complex legal concepts to diverse audiences.
Kevin`s contact details
******@crinetics.com
Colleagues
Vice President, Project, Portfolio and Alliance Management
Chief of Staff and Head of Portfolio Strategy
Vice President of Market Access
Executive Director, Head of Corporate Strategy
Scientific Advisory Board Member
Member Board of Directors
Vice President, Health Economics and Outcomes Research
Biopharmaceutical Program Leader
Vice President, Regulatory Affairs and Quality Assurance
Vice President, Marketing - Rare Diseases